BIOPHARMACEUTICAL EVALUATION OF SOME CONTROLLED RELEASE SYSTEMS OF CERTAIN ANTIEPILEPTIC DRUGS
Hind Al-Zein;
Abstract
Oxcarbazepine (OXC) is a new antiepileptic drug, that may be considered as the son of Carbamazepine (CBZ). OXC has been shown to be a weaker inducer of the liver enzymes than CBZ. This lower enzyme induction will improve the treatment of patients on polyt
Other data
| Title | BIOPHARMACEUTICAL EVALUATION OF SOME CONTROLLED RELEASE SYSTEMS OF CERTAIN ANTIEPILEPTIC DRUGS | Other Titles | التقييم الصيدلى الحيوى لبعض الانظمه المضاده للصرع ذات الانطلاق المنضبط | Authors | Hind Al-Zein | Keywords | BIOPHARMACEUTICAL EVALUATION OF SOME CONTROLLED RELEASE SYSTEMS OF CERTAIN ANTIEPILEPTIC DRUGS | Issue Date | 1998 | Description | Oxcarbazepine (OXC) is a new antiepileptic drug, that may be considered as the son of Carbamazepine (CBZ). OXC has been shown to be a weaker inducer of the liver enzymes than CBZ. This lower enzyme induction will improve the treatment of patients on polyt |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.